Wealthspire Advisors LLC Decreases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Wealthspire Advisors LLC reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 26.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,840 shares of the financial services provider’s stock after selling 4,243 shares during the period. Wealthspire Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,565,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in IBB. BNP Paribas Financial Markets raised its holdings in iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares during the period. Commerce Bank raised its stake in shares of iShares Biotechnology ETF by 1.8% in the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after acquiring an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after acquiring an additional 164,000 shares during the last quarter. Main Management ETF Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 2.5% during the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after purchasing an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC bought a new position in iShares Biotechnology ETF during the 4th quarter valued at about $18,476,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $138.74 on Tuesday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The company’s 50-day moving average is $135.64 and its 200 day moving average is $140.77.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.